A New Paradigm for Medical Enterprise Management in the Post-Pandemic Era
Are the time and cost of project implementation persistently high?
Talent Management Yielding Slow Results?
Struggling to Formulate and Implement Cost-Reduction and Efficiency-Enhancement Strategies?
......
In fact, these issues are themselves common challenges in the development of healthcare enterprises. However, the persistent and recurrent impact of the pandemic, coupled with an increasingly competitive market environment, has led to a more frequent occurrence of these problems, thereby introducing greater uncertainty into corporate development.
This phenomenon also reflects a trend, namelyOptimizing corporate management systems and reducing costs while improving efficiency have become one of the key directions for enterprise development.。
However, for many enterprises, although optimizing the management system is a correct choice that can bring more stable and long-term development, various problems are often encountered in the actual implementation process.
In summary, the optimization of management systems is essentially a change made by enterprises in pursuit of long-term development, involving organizational control, talent management, strategy implementation, and other aspects.In the face of continuously evolving market conditions, how should healthcare enterprises optimize their management systems? And where can they find the external expertise needed?
With these questions in mind,August 4, 2022, 20:00-21:30, VCBeat SelectJointCo-authored by KPMGheld《New Paradigms for Healthcare Enterprise Management in the Post-Pandemic Era》Live Online Open Class,Focusing on the Optimization of Enterprise Management Systems and Sharing Practical Experience Under the Impact of the Pandemic and Market Changes,Provide more feasible recommendations for advancing enterprise management.
In this open lecture, in addition to the course sharing on [New Reflections on the Management System of Medical Enterprises under the Epidemic] brought by senior practitioners from KPMG, there is alsoKPMG, Chaoju Eye Care, Guyitang, 3SBio, Dongfang BeiliThe roundtable discussion on the theme of “[Challenges and Breakthroughs in Management Systems in the Post-Pandemic Era]” will address issues such as management system challenges and upgrades, helping enterprises identify pathways for optimizing their management systems more rapidly.
In addition, we will also provide extraOpen Course Preview Materials, Healthcare Enterprise Management Documents, and Premium Industry Reports on Medical Healthand other valuable perks,Scan the QR code on the poster belowAvailable upon registration for the event.
Top 20Participants in the registration will also have1-Month Free Membership Benefit Package for VBInsightClaimable! First come, first served!
With years of dedicated consulting experience in the broader health sector, possesses extensive expertise in platform ecosystem development, organizational governance, and talent empowerment.
Chief Physician, Master’s Supervisor. Currently serves as a member of the 10th Committee of the Ophthalmology Branch of the Inner Mongolia Medical Association, a member of the Ophthalmology Sub-branch of Medical Device Management under the China Medicine Education Association, a member of the Ophthalmology Professional Committee of the Chinese Non-Public Healthcare Institutions Association, and a Master’s Supervisor at Baotou Medical College, Inner Mongolia University of Science and Technology.
Founder, Chairman, and CEO of Gu Yitang, with extensive experience in the internet-based and digital transformation of Traditional Chinese Medicine (TCM). Currently serves as Vice President of the Hunan Provincial Food Standardization Association, Visiting Professor at the School of Humanities and Management, Hunan University of Chinese Medicine, Vice Chairman of the Professional Committee on TCM Clinics and Community Services under the World Federation of Chinese Medicine Societies, and Executive Director of the Second TCM Preventive Treatment of Disease Professional Committee of the Hunan Health Management Society.
Currently serves as Executive Director of Dongfang Beili, Director of the Joint Center for Nutrition and Health Evaluation at the Beijing Institute of Nutritional Resources (affiliated with Dongfang Beili), and Vice Chairman of the Beijing Food Science Society.
Ph.D. in Pharmacy from Shenyang Pharmaceutical University; MBA from Shanghai Advanced Institute of Finance (SAIF), Shanghai Jiao Tong University. With over 15 years of experience in the pharmaceutical industry, has led or participated in more than 30 business development (BD) and investment projects, including out-licensing and in-licensing deals, with a total transaction value exceeding RMB 3.5 billion. Has published more than 30 scientific papers in the pharmaceutical field and received awards for scientific and technological progress. Has overseen the project initiation and development of over 40 pharmaceutical products, demonstrating extensive industrial expertise. Proficient in the end-to-end process of new drug project initiation and development, as well as the full spectrum of business development operations in the biopharmaceutical sector, with in-depth knowledge of the current landscape and development trends of the pharmaceutical industry.
About KPMG
KPMG is a global organization composed of independent professional member firms. As one of the Big Four accounting firms and a world-leading professional services provider, KPMG specializes in audit, tax, and advisory services, helping clients achieve their business objectives and address challenges.
About Chaoju Eye Care
Since its founding, Chaoju Eye Care has upheld the vision of “A Century of Chaoju, Toward Light, Gathering Hope,” providing patients with a reassuring, safe, and affordable ophthalmic care environment, professional and effective equipment and technologies, and thoughtful, patient-centered service experiences. The company has established an extensive network of ophthalmic hospitals and optometry centers, comprising 17 ophthalmic hospitals and 23 optometry centers across five provinces or autonomous regions in China, with a strong presence in North China.
About Guyitang
Gu Yitang (Hunan) Health Technology Co., Ltd. was established in 2014 and is among the first enterprises in Hunan Province to obtain an internet hospital license. The company is committed to building the most influential integrated health management service platform, making comprehensive health management services more accessible through platform openness. To date, its subsidiaries with various industrial functions include: Yinchuan Gu Yitang Internet Hospital Co., Ltd., Hunan Gu Yitang Chain Traditional Chinese Medicine Clinic Co., Ltd., Hunan Gu Yitang Chain Pharmacy Co., Ltd., Hunan Gu Yitang Health Management Co., Ltd., Hunan Jizhong Huitong Pharmaceutical Co., Ltd., and Hunan Yaoshi Huake Technology Co., Ltd., among others. The company operates a research and development laboratory established through a strategic partnership with the Hunan Academy of Traditional Chinese Medicine, has independently developed nearly 100 products across five major series, and has been recognized as a “High-Tech Enterprise of Hunan Province.”
About Dongfang Beili
Since its establishment over two decades ago, the Oriental Beili brand has continuously expanded and strengthened. It has independently developed a comprehensive industry chain integrating production, academia, research, and application, with the Oriental Beili Health Research Institute as its scientific research entity, Beijing Oriental Beili Nutrition Technology Co., Ltd. as its operational entity, Oriental Beike (Tianjin) Nutrition Food Co., Ltd. as its manufacturing entity, and Beijing Oriental Beili Technology Co., Ltd. as its health management service entity. The company provides consumers with high-quality nutritional products and a diverse range of health management services, including health assessments, exercise guidance, and nutritional interventions.
About 3SBio
3SBio Inc. is committed to addressing clinical medication challenges for patients, continuously overcoming disease-related hurdles, and improving patients’ quality of life with high-quality pharmaceuticals, thereby contributing to human health. Leveraging a professional R&D team comprising over 380 scientists, the company operates four comprehensive R&D centers, including the National Engineering Research Center for Antibody Drugs and dual platforms for biologics and chemical drugs. The company is actively advancing the development of innovative therapies, such as monoclonal antibodies, bispecific antibodies, antibody fusion proteins, and cell therapies, to provide patients with a diverse range of treatment options.
VCBeat Open Course
“Artery Open Course” is one of the branded columns under VCBeat’s “VCBeat Select.” Focusing on pain points in the medical industry and systematic solutions, it leverages an online live-streaming platform for knowledge sharing and exchange. By continuously inviting seasoned industry practitioners and experts to collaboratively develop a series of thematic courses, it aims to provide healthcare enterprises with in-depth, high-value content. Artery Open Course: Making the selection of knowledge simpler.